To view digital features for this article go to Introduction Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are successfully used in the treatment of type 2 diabetes mellitus, improving glycaemic control with low risk of hypoglycaemia and inducing weight loss [1, 2]
In the United Kingdom, you must defer your donation if youve had a recent course of steroid tablets or injections
Less common but more serious side effects that require medical attention include: Pancreatitis (inflammation of the pancreas) characterised by severe, persistent abdominal pain Diabetic retinopathy complications particularly in patients with pre-existing eye disease Hypoglycaemia (low blood sugar) especially when used alongside insulin or sulphonylureas Acute kidney injury often secondary to severe dehydration from vomiting or diarrhoea Gallbladder problems including gallstones and cholecystitis (watch for right upper abdominal pain, fever, or jaundice) Hypersensitivity reactions such as rash, urticaria, or rarely, anaphylaxis Injection site reactions including redness or irritation at the injection site Regarding hearing loss , there is currently no established causal link between Ozempic and auditory impairment in the official product literature or regulatory guidance from the MHRA or EMA (European Medicines Agency)
Wegovy, on the other hand, is a brand name for semaglutide, a GLP-1 receptor agonist produced by Novo Nordisk, which has been widely used for the management of obesity
Yahoo Finance, August 2, 2024
In some patients glutathione can begin to move toxins which means it is working, however, the initial after-effect can leave them feeling worse than when they came in
![GLP-1 RAs and Skin Health: Exploring Dermatologic Side Effects and Therapeutic Interventions[v1]](https://www.preprints.org/frontend/picture/ms_xml/manuscript/b0714be486d8e9fe95dfcbc85df1634c/preprints-164552-g001.png)
